retatrutide cycle Research Guide: What the Phase 2 Trial Data Reported (2026) Retatrutide—A Game Changer in Obesity

In another 2025 study by Qeadan and colleagues that used electronic health data from over 1.3 million individuals with a history of alcohol use disorder and opioid use disorder, researchers found that individuals with alcohol use disorder (n=817,309) prescribed GLP-1 medications experienced about 50% fewer alcohol intoxication events over the 2-year period compared to patients who didnt receive the medications (Qeadan et al., 2025)

It should be remembered that PFS final rules typically follow the codes, code descriptors and parenthetical notes as found in each new edition of CPT

Follow label for storage instructions Step 8

P., Jr, Nichenametla, S., Neidig, W., Calcagnotto, A., Haley, J